关注
Heather Parsons
Heather Parsons
Dana-Farber Cancer Institute
在 dfci.harvard.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors
VA Adalsteinsson, G Ha, SS Freeman, AD Choudhury, DG Stover, ...
Nature communications 8 (1), 1324, 2017
7952017
TBCRC 022: a phase II trial of neratinib and capecitabine for patients with human epidermal growth factor receptor 2–positive breast cancer and brain metastases
RA Freedman, RS Gelman, CK Anders, ME Melisko, HA Parsons, ...
Journal of Clinical Oncology 37 (13), 1081-1089, 2019
3162019
DNA binding features of human POT1: a nonamer 5′-TAGGGTTAG-3′ minimal binding site, sequence specificity, and internal binding to multimeric sites
D Loayza, H Parsons, J Donigian, K Hoke, T de Lange
Journal of Biological Chemistry 279 (13), 13241-13248, 2004
2562004
Association of cell-free DNA tumor fraction and somatic copy number alterations with survival in metastatic triple-negative breast cancer
DG Stover, HA Parsons, G Ha, SS Freeman, WT Barry, H Guo, ...
Journal of Clinical Oncology 36 (6), 543-553, 2018
2252018
ESR1 Mutations in Circulating Plasma Tumor DNA from Metastatic Breast Cancer Patients
D Chu, C Paoletti, C Gersch, DA VanDenBerg, DJ Zabransky, ...
Clinical cancer research 22 (4), 993-999, 2016
1852016
Circulating tumor DNA in advanced solid tumors: clinical relevance and future directions
ML Cheng, E Pectasides, GJ Hanna, HA Parsons, AD Choudhury, ...
CA: a cancer journal for clinicians 71 (2), 176-190, 2021
1452021
Sensitive detection of minimal residual disease in patients treated for early-stage breast cancer
HA Parsons, J Rhoades, SC Reed, G Gydush, P Ram, P Exman, K Xiong, ...
Clinical Cancer Research 26 (11), 2556-2564, 2020
1342020
Tumor fraction in cell-free DNA as a biomarker in prostate cancer
AD Choudhury, L Werner, E Francini, XX Wei, G Ha, SS Freeman, ...
JCI insight 3 (21), 2018
1132018
Comparison of cell stabilizing blood collection tubes for circulating plasma tumor DNA
PV Toro, B Erlanger, JA Beaver, RL Cochran, DA VanDenBerg, E Yakim, ...
Clinical biochemistry 48 (15), 993-998, 2015
982015
HER2 missense mutations have distinct effects on oncogenic signaling and migration
DJ Zabransky, CL Yankaskas, RL Cochran, HY Wong, S Croessmann, ...
Proceedings of the National Academy of Sciences 112 (45), E6205-E6214, 2015
952015
Personalized medicine in the oncology clinic: implementation and outcomes of the Johns Hopkins molecular tumor board
WB Dalton, PM Forde, H Kang, RM Connolly, V Stearns, CD Gocke, ...
JCO precision oncology 1, 1-19, 2017
872017
Circulating tumor DNA and late recurrence in high-risk hormone receptor–positive, human epidermal growth factor receptor 2–negative breast cancer
M Lipsyc-Sharf, EC de Bruin, K Santos, R McEwen, D Stetson, A Patel, ...
Journal of Clinical Oncology 40 (22), 2408-2419, 2022
712022
Individualized molecular analyses guide efforts (IMAGE): a prospective study of molecular profiling of tissue and blood in metastatic triple-negative breast cancer
HA Parsons, JA Beaver, A Cimino-Mathews, SM Ali, J Axilbund, D Chu, ...
Clinical Cancer Research 23 (2), 379-386, 2017
622017
A framework for clinical cancer subtyping from nucleosome profiling of cell-free DNA
AL Doebley, M Ko, H Liao, AE Cruikshank, K Santos, C Kikawa, JB Hiatt, ...
Nature Communications 13 (1), 7475, 2022
452022
Massively parallel enrichment of low-frequency alleles enables duplex sequencing at low depth
G Gydush, E Nguyen, JH Bae, T Blewett, J Rhoades, SC Reed, D Shea, ...
Nature Biomedical Engineering 6 (3), 257-266, 2022
432022
Circulating plasma tumor DNA
HA Parsons, JA Beaver, BH Park
Novel Biomarkers in the Continuum of Breast Cancer, 259-276, 2016
392016
NDRG1 links p53 with proliferation-mediated centrosome homeostasis and genome stability
S Croessmann, HY Wong, DJ Zabransky, D Chu, J Mendonca, A Sharma, ...
Proceedings of the National Academy of Sciences 112 (37), 11583-11588, 2015
332015
Response to Olaparib in a Patient with Germline BRCA2 Mutation and Breast Cancer Leptomeningeal Carcinomatosis
P Exman, RM Mallery, NU Lin, HA Parsons
NPJ Breast Cancer 5 (1), 46, 2019
282019
Liquid biopsy epigenomic profiling for cancer subtyping
SC Baca, JH Seo, MP Davidsohn, B Fortunato, K Semaan, S Sotudian, ...
Nature medicine 29 (11), 2737-2741, 2023
242023
Aiming at a tailored cure for ERBB2-positive metastatic breast cancer: a review
P Tarantino, G Curigliano, HA Parsons, NU Lin, I Krop, EA Mittendorf, ...
JAMA oncology 8 (4), 629-635, 2022
232022
系统目前无法执行此操作,请稍后再试。
文章 1–20